# Asociación Europea para el Estudio de la Diabetes (EASD) 2025 (Parte 2)
URL canonica: https://calculadoras.nmn.mx/infografias/asociacion-europea-estudio-diabetes-easd-2025-parte-2  
Tipo: INFOGRAFIA  
Audiencia: Profesionales de la salud  
Areas terapeuticas: Cardiometabolico  
Padecimientos: Diabetes  
Fecha de publicacion: 2025-11-18T00:00:00.000Z  
Ultima actualizacion: 2026-04-17T18:35:31.000Z  
![Asociación Europea para el Estudio de la Diabetes (EASD) 2025 (Parte 2)](https://apimedpoint.nmn.mx/uploads/contenidos/portadas/ejercicios_para_disminuir_los_sintomas_ocasionados_por_la_radiculopatia_-01.jpg)
## Resumen
## Contenido

## Referencias

- Speight, J., Hermanns, N., Jensen, W., Kanc, K., Karagiannis, T., Law, M., Mocan, A., Rutters, F., Sturt, J., Zaccardi, F., & Holt, R. I. G. (2026). 2026 EASD evidence-based clinical practice guideline for assessing and managing diabetes distress among adults with type 1 diabetes and type 2 diabetes. European Association for the Study of Diabetes (EASD) [Preprint]. https://www.easd.org/uploads/Final-Draft_EASD-Diabetes-Distress-Guidelin...
- Chiriacò, M., Trico, D., Nesti, L., Sacchetta, L., Cimbalo, N., Santoni, L., Gallo, S., Simona, B., Hansen, M. K., & Ferrannini, E. (2025). Impact of background insulin treatment on cardiorenal outcomes in patients with type 2 diabetes: a patient-level analysis of merged CANVAS and CREDENCE trials. Diabetologia, 68(Suppl. 1): S5. [https://doi.org/10.1007/s00125-025-06497-1](https://doi.org/10.1007/s00125-025-06497-1)
- Sabatini S., Bugianesi E., Allison M., Vidal-Puig A., Schattenberg J.M., Ratziu V., Anstee Q.M., Gastaldelli A. (2025). The severity of metabolic dysfunction-associated steatohepatitis is associated with adipose tissue dysfunction and insulin resistance rather than BMI. Diabetologia, 68(Suppl. 1):S19. [https://doi.org/10.1007/s00125-025-06497-1](https://doi.org/10.1007/s00125-025-06497-1)
- Xourafa G., Granata C., Trenkamp S., Korzekwa B., Schrauwen-Hinderling V., Petersen K., Shulman G., Kahl S., Roden M. (2025). White adipose tissue adapts first: increased mitochondrial respiration and insulin resistance after short-term high-fat diet in healthy adults. Diabetologia, 68(Suppl. 1)S:133. [https://doi.org/10.1007/s00125-025-06497-1](https://doi.org/10.1007/s00125-025-06497-1)
- Holt, R. I. G., Hess-Fischl, A., DeVries, J. H., et al. (2026). The management of type 1 diabetes in adults. The updated 2026 consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Consensus Report. [Preprint]. [https://professional.diabetes.org/sites/dpro/files/2025-09/2026-ADA-EASD...](https://professional.diabetes.org/sites/dpro/files/2025-09/2026-ADA-EASD-Management-of-Type-1) -Diabetes-Consensus-Report-Draft-for-consultation.pdf
- Tucker, M. E. (2025, 24 de septiembre). EASD/ADA Draft Updates Type 1 Diabetes Management Guidance. Medscape Medical News. [https://www.medscape.com/viewarticle/easd-ada-draft-updates-type-1-diabe...](https://www.medscape.com/viewarticle/easd-ada-draft-updates-type-1-diabetes-management-guida) nce-2025a1000phl
- Jansz T., Young K., Shields B., Jones A., Hattersley A., Pearson E., Oram R., Dennis, J. (2025). Precision medicine in type 2 diabetes: targeting GLP1 receptor agonist and SGLT2-inhibitor combination treatment for kidney protection. Diabetologia, 68 (Suppl. 1): S69-S70. [https://doi.org/10.1007/s00125-025-06497-1](https://doi.org/10.1007/s00125-025-06497-1)